Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer [Phase 2]
Phase 2 trial results evaluate fenretinide in men with biochemically recurrent, hormone-naïve prostate cancer; the study is completed and re…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating S0114 vaccine therapy in patients with brain tumors, gastric cancer, ovarian cancer, or prostate cancer ha…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy [Phase 3]
Phase 3 trial evaluating quality of life in prostate cancer patients by randomizing anti-androgen therapy versus total androgen blockade pri…
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer [Phase 1]
A Phase 1 feasibility and safety study of preoperative high-dose single-fraction image-guided radiotherapy before radical prostatectomy in m…
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer [Phase 2]
A phase 2 trial of sorafenib for hormone-naïve biochemical recurrence of prostate cancer was withdrawn, with no results reported.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating dorsal penile block to alleviate Foley catheter discomfort after robotic prostatectomy has been withdr…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study [NA]
A completed case-control study in elderly patients 75+ who were treated and cured for localized prostate cancer, comparing them with a healt…
-
FDA approval · 2015-03-03FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for ZYTIGA (abiraterone acetate) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS research · 2015-03-02Clinical Trial Update: Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer
A clinical trial update describes the development of a safer, more accurate biopsy device for suspected prostate cancer, with the trial stat…
-
FDA approval · 2015-02-27FDA Approved: CASODEX — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CASODEX (bicalutamide) by ANI Pharmaceuticals, Inc.
-
FDA approval · 2015-02-26FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA has approved a supplemental application for FIRMAGON (degarelix) from Ferring Pharmaceuticals Inc. to modify the existing approval.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Perifosine in Treating Patients With Recurrent Prostate Cancer [Phase 2]
Phase 2 trial of perifosine in recurrent prostate cancer was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans [Phase 1]
Phase 1 trial assessed the safety and preliminary efficacy of irreversible electroporation to ablate prostate cancer in humans, and the stud…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies [Phase 1]
A Phase 1 study of MDX-1106 in patients with selected refractory or relapsed malignancies has completed, with results posted in 2015. The tr…
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer [NA]
This entry notes the completion of a feasibility Nordic lifestyle intervention trial for men with prostate cancer sponsored by the Danish Ca…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer [NA]
This completed clinical trial evaluated whether fish oil and green tea extract could help prevent prostate cancer in men at risk, with resul…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
This update reports results from a Phase I/II study of TRC105 in metastatic castration-resistant prostate cancer. The trial has completed an…
-
CLINICAL_TRIALS research · 2015-02-09Clinical Trial Update: Simultaneous CBCT Acquisition During Arc Radiotherapy [NA]
Clinical trial update on simultaneous cone-beam CT acquisition during arc radiotherapy for prostate and lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) [Phase 1, Phase 2]
A Phase 1/2 study evaluating safety, tolerability, and activity of lonafarnib in combination with docetaxel (Study P04467AM1) was terminated…
-
FDA approval · 2015-02-03FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) submitted by Verity Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer [Phase 1]
A phase 1 clinical trial evaluating Sunitinib Malate in combination with hormone ablation and radiation therapy in patients with prostate ca…
-
FDA approval · 2015-01-26FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc., authorizing an update to th…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking [Phase 2]
Phase 2 trial update on memantine hydrochloride for helping cancer survivors stop smoking.
-
CLINICAL_TRIALS withdrawal · 2015-01-26Clinical Trial Update: A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy [Phase 2]
A Phase II neoadjuvant study of enzalutamide, abiraterone acetate, dutasteride, and degarelix in men with localized prostate cancer was with…
-
CLINICAL_TRIALS research · 2015-01-26Clinical Trial Update: Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT [Phase 2]
Phase 2 feasibility trial comparing CyberKnife SBRT versus VMAT SBRT for localized prostate cancer; no results are reported in the document.